BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 21468922)

  • 1. Matrix metalloproteinase-13 expression in IL-1β-treated chondrocytes by activation of the p38 MAPK/c-Fos/AP-1 and JAK/STAT pathways.
    Lim H; Kim HP
    Arch Pharm Res; 2011 Jan; 34(1):109-17. PubMed ID: 21468922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3.
    Mengshol JA; Vincenti MP; Coon CI; Barchowsky A; Brinckerhoff CE
    Arthritis Rheum; 2000 Apr; 43(4):801-11. PubMed ID: 10765924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MyD88, IRAK1 and TRAF6 knockdown in human chondrocytes inhibits interleukin-1-induced matrix metalloproteinase-13 gene expression and promoter activity by impairing MAP kinase activation.
    Ahmad R; Sylvester J; Zafarullah M
    Cell Signal; 2007 Dec; 19(12):2549-57. PubMed ID: 17905570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenyl N-tert-butylnitrone down-regulates interleukin-1 beta-stimulated matrix metalloproteinase-13 gene expression in human chondrocytes: suppression of c-Jun NH2-terminal kinase, p38-mitogen-activated protein kinase and activating protein-1.
    Ahmed S; Rahman A; Hasnain A; Goldberg VM; Haqqi TM
    J Pharmacol Exp Ther; 2003 Jun; 305(3):981-8. PubMed ID: 12626640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-1 beta promotes A549 cell migration via MAPKs/AP-1- and NF-kappaB-dependent matrix metalloproteinase-9 expression.
    Lin CC; Kuo CT; Cheng CY; Wu CY; Lee CW; Hsieh HL; Lee IT; Yang CM
    Cell Signal; 2009 Nov; 21(11):1652-62. PubMed ID: 19616091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1beta induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kappaB signaling pathways in human tracheal smooth muscle cells.
    Liang KC; Lee CW; Lin WN; Lin CC; Wu CB; Luo SF; Yang CM
    J Cell Physiol; 2007 Jun; 211(3):759-70. PubMed ID: 17311279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Wnt-5A in interleukin-1beta-induced matrix metalloproteinase expression in rabbit temporomandibular joint condylar chondrocytes.
    Ge X; Ma X; Meng J; Zhang C; Ma K; Zhou C
    Arthritis Rheum; 2009 Sep; 60(9):2714-22. PubMed ID: 19714632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of flavonoids on matrix metalloproteinase-13 expression of interleukin-1β-treated articular chondrocytes and their cellular mechanisms: inhibition of c-Fos/AP-1 and JAK/STAT signaling pathways.
    Lim H; Park H; Kim HP
    J Pharmacol Sci; 2011; 116(2):221-31. PubMed ID: 21606625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronan inhibits matrix metalloproteinase-13 in human arthritic chondrocytes via CD44 and P38.
    Julovi SM; Ito H; Nishitani K; Jackson CJ; Nakamura T
    J Orthop Res; 2011 Feb; 29(2):258-64. PubMed ID: 20706991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor gamma1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1beta in articular chondrocytes.
    Afif H; Benderdour M; Mfuna-Endam L; Martel-Pelletier J; Pelletier JP; Duval N; Fahmi H
    Arthritis Res Ther; 2007; 9(2):R31. PubMed ID: 17386086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional activation of c-Fos by constitutively active Galpha(16)QL through a STAT1-dependent pathway.
    Lo RK; Wong YH
    Cell Signal; 2006 Dec; 18(12):2143-53. PubMed ID: 16781847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigallocatechin-3-gallate selectively inhibits interleukin-1beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes.
    Singh R; Ahmed S; Malemud CJ; Goldberg VM; Haqqi TM
    J Orthop Res; 2003 Jan; 21(1):102-9. PubMed ID: 12507586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aurothiomalate inhibits cyclooxygenase 2, matrix metalloproteinase 3, and interleukin-6 expression in chondrocytes by increasing MAPK phosphatase 1 expression and decreasing p38 phosphorylation: MAPK phosphatase 1 as a novel target for antirheumatic drugs.
    Nieminen R; Korhonen R; Moilanen T; Clark AR; Moilanen E
    Arthritis Rheum; 2010 Jun; 62(6):1650-9. PubMed ID: 20178133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAPKs, activator protein-1 and nuclear factor-κB mediate production of interleukin-1β-stimulated cytokines, prostaglandin E₂ and MMP-1 in human periodontal ligament cells.
    Murayama R; Kobayashi M; Takeshita A; Yasui T; Yamamoto M
    J Periodontal Res; 2011 Oct; 46(5):568-75. PubMed ID: 21615409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase (MMP)-12 regulates MMP-9 expression in interleukin-1beta-treated articular chondrocytes.
    Oh H; Yang S; Park M; Chun JS
    J Cell Biochem; 2008 Dec; 105(6):1443-50. PubMed ID: 18980250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of p42/p44 MAPK, p38 MAPK, JNK and nuclear factor-kappa B in interleukin-1beta-induced matrix metalloproteinase-9 expression in rat brain astrocytes.
    Wu CY; Hsieh HL; Jou MJ; Yang CM
    J Neurochem; 2004 Sep; 90(6):1477-88. PubMed ID: 15341531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vorinostat, a HDAC inhibitor, showed anti-osteoarthritic activities through inhibition of iNOS and MMP expression, p38 and ERK phosphorylation and blocking NF-κB nuclear translocation.
    Zhong HM; Ding QH; Chen WP; Luo RB
    Int Immunopharmacol; 2013 Oct; 17(2):329-35. PubMed ID: 23856614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1 beta induction of matrix metalloproteinase-1 transcription in chondrocytes requires ERK-dependent activation of CCAAT enhancer-binding protein-beta.
    Raymond L; Eck S; Mollmark J; Hays E; Tomek I; Kantor S; Elliott S; Vincenti M
    J Cell Physiol; 2006 Jun; 207(3):683-8. PubMed ID: 16453302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway.
    Li WQ; Dehnade F; Zafarullah M
    J Immunol; 2001 Mar; 166(5):3491-8. PubMed ID: 11207308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibronectin fragments and blocking antibodies to alpha2beta1 and alpha5beta1 integrins stimulate mitogen-activated protein kinase signaling and increase collagenase 3 (matrix metalloproteinase 13) production by human articular chondrocytes.
    Forsyth CB; Pulai J; Loeser RF
    Arthritis Rheum; 2002 Sep; 46(9):2368-76. PubMed ID: 12355484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.